The mission of the Research Training and information transfer Core (RTITC) is to provide a enhance mechanisms to impart information about Alzheimer's disease and related dementias to persons with dementia and their caregivers, to health care providers, to other groups throughout the community who interface with these two populations, and to researchers in basic and clinical sciences. Although there are currently several programs which provide educational services throughout the region, the RTITC has established better coordination and integration of such programs as a high priority; while integration among these programs has not been maximized, it is the cooperation that already exists among these organizations that makes the proposed RTITC objectives attainable. The proposed RTITC goals differ from those currently in place in that they focus on evaluaitona nd impact of educational efforts, remove goals related to direct service, place a greater emphasis on disseminating information about dementia-related research initiatives, and increase integration between the RTITC and the Clinical Core. The RTITC proposes the following; (1) To increase community awareness of dementia particularly in areas in which there have been no such programs; (2) To better coordinate and enhance the efficiency and effectiveness of educational programs and information transfer initiatives in both the University and in the community; (3) To identify gaps in educational programming and in target audiences; (4) To increase marketing efforts to promote dementia-related research throughout the community; and (5) To evaluate the impacts of education transfer efforts and to enhance accountability of ADCC Information Transfer initiatives. The RTTTC will contract with the Rochester Chapter of the Alzheimer's Association and with the Monroe Community Hospital Alzheimer's Family Outreach Program to assist in carrying out the proposed community-based goals.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG008665-07
Application #
5204615
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1996
Total Cost
Indirect Cost
Chapman, Robert M; Gardner, Margaret N; Mapstone, Mark et al. (2015) Memory timeline: Brain ERP C250 (not P300) is an early biomarker of short-term storage. Brain Res 1604:74-83
Chapman, Robert M; Porsteinsson, Anton P; Gardner, Margaret N et al. (2013) C145 as a short-latency electrophysiological index of cognitive compensation in Alzheimer's disease. J Alzheimers Dis 33:55-68
Chapman, Robert M; Mapstone, Mark; Gardner, Margaret N et al. (2011) Women have farther to fall: gender differences between normal elderly and Alzheimer's disease in verbal memory engender better detection of Alzheimer's disease in women. J Int Neuropsychol Soc 17:654-62
Chapman, Robert M; Mapstone, Mark; McCrary, John W et al. (2011) Predicting conversion from mild cognitive impairment to Alzheimer's disease using neuropsychological tests and multivariate methods. J Clin Exp Neuropsychol 33:187-99
Chapman, Robert M; McCrary, John W; Gardner, Margaret N et al. (2011) Brain ERP components predict which individuals progress to Alzheimer's disease and which do not. Neurobiol Aging 32:1742-55
Chapman, Robert M; Mapstone, Mark; Porsteinsson, Anton P et al. (2010) Diagnosis of Alzheimer's disease using neuropsychological testing improved by multivariate analyses. J Clin Exp Neuropsychol 32:793-808
Price, Joseph L; McKeel Jr, Daniel W; Buckles, Virginia D et al. (2009) Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 30:1026-36
Chapman, Robert M; Nowlis, Geoffrey H; McCrary, John W et al. (2007) Brain event-related potentials: diagnosing early-stage Alzheimer's disease. Neurobiol Aging 28:194-201
Hurley, Sean D; Coleman, Paul D (2003) Facial nerve axotomy in aged and young adult rats: analysis of the glial response. Neurobiol Aging 24:511-8
Porsteinsson, Anton P; Tariot, Pierre N; Jakimovich, Laura J et al. (2003) Valproate therapy for agitation in dementia: open-label extension of a double-blind trial. Am J Geriatr Psychiatry 11:434-40

Showing the most recent 10 out of 66 publications